keine Finanzberatung

BDX · Becton, Dickinson and Co.

Medical devices: syringes, diagnostics, drug delivery

Risiko 3/10 · LOW-MODERATE RISK · defensive medtech · $184.74 ▼ 1.54%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $184.74
  • Market cap $50.3B
  • P/E (ttm) 31.96
  • Div yield 2.27%
  • 52-wk range $127.59 – $193.07
  • Index rank #252 / —

Wichtigste Risiken

  • Product recalls and FDA enforcement actions (Customers) — MED
  • Execution risk in the planned biosciences separation (Shareholders) — MED
  • Litigation overhang from legacy products (Shareholders) — MED
  • GAAP earnings persistently lagging the adjusted story (Shareholders) — LOW

Fazit

A defensive dividend stalwart best suited to patient, income-oriented investors.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.